How Macrophage Swelling Triggers Stronger Immune Defenses Against Viruses

A new study from the University of Manchester has revealed how changes in macrophage cell volume influence immune responses. The findings, set to appear in the Journal of Cell Biology on 7 May 2026, highlight a previously unknown link between cell swelling and the regulation of inflammatory and antiviral genes. This discovery could pave the way for fresh approaches in treating inflammatory diseases and viral infections. Macrophages play a central role in the body’s defence against infections and tissue injury. These immune cells rely on the Volume Regulated Anion Channel (VRAC) to maintain proper osmotic balance. When VRAC function is impaired, exposure to low-osmolarity conditions causes rapid and excessive swelling in macrophages.

The study demonstrated that this swelling triggers a dramatic shift in gene activity. Genes linked to type I interferon signalling, nucleic acid detection, and proinflammatory responses showed marked increases. Researchers also observed that VRAC-deficient macrophages mounted a stronger antiviral reaction when exposed to Influenza A virus in lab experiments. To test real-world relevance, the team used a mouse model of severe inflammation. Animals lacking VRAC produced far higher levels of key proinflammatory cytokines during systemic inflammatory challenges. These results suggest that cell volume changes act as a danger signal, prompting macrophages to ramp up immune defences.

The findings point to VRAC and cell volume regulation as potential targets for new therapies. By modulating these pathways, scientists may develop better ways to control inflammatory disorders and viral infections. The study also underscores the need for further research into how macrophages interpret and react to danger signals at the molecular level.